Results 1 to 10 of about 3,389,488 (311)

Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19 [PDF]

Frontiers in Immunology
Tetiana Yatsenko, Tetiana Yatsenko, Ricardo Rios, Tatiane Nogueira, Yousef Salama, Satoshi Takahashi, Yoko Tabe, Toshio Naito, Kazuhisa Takahashi, Kazuhisa Takahashi, Koichi Hattori, Koichi Hattori, Beate Heissig   +12 more
doaj   +2 more sources

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Journal of the American Medical Association (JAMA), 1995
OBJECTIVE To evaluate the efficacy and safety of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke.
W. Hacke, M. Kaste, C. Fieschi, D. Toni, E. Lesaffre, R. von Kummer, G. Boysen, E. Bluhmki, G. Höxter, M. Mahagne   +9 more
semanticscholar   +1 more source

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

New England Journal of Medicine, 1985
Certain risk factors for myocardial infarction have been linked with disturbances in fibrinolytic activity. The recent development in our laboratory of new sensitive and specific methods for determination of tissue plasminogen activator (t-PA) activity ...
A. Hamsten, B. Wiman, U. de Faire, M. Blombäck   +3 more
semanticscholar   +1 more source

Intrapleural use of tissue plasminogen activator and DNase in pleural infection.

New England Journal of Medicine, 2011
BACKGROUND More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial.
Najib M. Rahman, Nicholas A. Maskell, A. West, R. Teoh, A. Arnold, C. Mackinlay, D. Peckham, Chris W.H. Davies, N. Ali, W. Kinnear, A. Bentley, B. Kahan, J. Wrightson, Helen E. Davies, Clare E. Hooper, Y.C. Gary Lee, E. Hedley, N. Crosthwaite, L. Choo, Emma J. Helm, F. V. Gleeson, Andrew J. Nunn, Robert J. O. Davies   +22 more
semanticscholar   +1 more source

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

New England Journal of Medicine, 1987
We compared the efficacy of immediate coronary angioplasty after acute myocardial infarction with that of elective angioplasty at 7 to 10 days in patients treated initially with intravenous tissue plasminogen activator. The plasminogen activator (150 mg)
E. Topol, R. Califf, B. George, D. Kereiakes, C. Abbottsmith, R. Candela, K. Lee, B. Pitt, R. Stack, W. O’Neill   +9 more
semanticscholar   +1 more source

Plasminogen-activator inhibitor type 1 and coronary artery disease.

New England Journal of Medicine, 2000
The development of coronary artery disease, and specifically myocardial infarction, involves hyperplasia of arterial smooth muscle, the development of fatty streaks, atheroma formation, plaque rupture, and ultimately thrombus formation and vessel ...
H. Kohler, P. Grant
semanticscholar   +1 more source

The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis

Seminars in Thrombosis and Hemostasis, 2016
P. Flevaris, Douglas E. Vaughan
semanticscholar   +1 more source

The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies

Expert opinion on therapeutic targets, 2016
S. Su, Chiao-Wen Lin, Wei-En Yang, W. Fan, Shun-Fa Yang   +4 more
semanticscholar   +1 more source

Involvement of Urokinase‐Type Plasminogen Activator System in Cancer: An Overview

Medicinal research reviews (Print), 2014
Ahmed H. Mekkawy, M. Pourgholami, D. Morris   +2 more
semanticscholar   +1 more source

Breaking the fibrinolytic speed limit with microwheel co‐delivery of tissue plasminogen activator and plasminogen

Journal of Thrombosis and Haemostasis, 2022
Dante Disharoon, Brian G Trewyn, Paco S Herson   +2 more
exaly